TelyRx Holdings Inc. (TSX:TELY)
2.410
-0.040 (-1.63%)
At close: Jun 24, 2026
TelyRx Holdings Earnings Call Transcripts
Fiscal Year 2026
-
A digital pharmacy platform has achieved rapid growth by offering over 450 everyday medications with same-day delivery, transparent pricing, and no insurance required, targeting the $98 billion cash-pay market. With $43 million in 2025 revenue, strong repeat customer rates, and scalable operations, it is positioned for continued expansion and margin improvement.
-
Q1 2026 revenue surged 180% year-over-year to $19.4M, with prescriptions filled up 188%. Gross margin improved to 55%, and management expects to achieve over $100M in 2026 revenue, with positive EBITDA for the year.